comparemela.com

Latest Breaking News On - Ibrosis pulmonary - Page 2 : comparemela.com

Diagnosing Progressive Pulmonary Fibrosis

Renowned medical professionals and experts congregated in Milan to explore the current and future prospects of diagnosing PPF.

University hospitalNew yorkUnited statesZuid hollandUnited kingdomMarliess wijsenbeekElisabeth robertsonMichael kreuterAnna podolanczukWeill cornell medical collegeEuropean respiratory societyLung center at university hospitalNew york cityLung centerInterstitial lung disease centreErasmus university medical centre

ERS 2023: Seeking a Healthy Environment for the Lungs

The hybrid meeting promises education, collaboration, and a focus on climate change for professionals in pulmonary and critical care medicine.

Katerina antoniouGerriet blumTorsten gerriet blumNajibm rahmanApostolos bossiosWinfried randerathMarisa bonsignoreChristian karagiannidisMona lichtblauOmar usmaniCarlos winckMarielle pijnenburgMichael kreuterHolly keirPrecision medicine in airway diseaseInternational congress

FibroGen s Lung Disease Drug Fails Late-Stage Trial

FibroGen said on Monday its experimental drug for a chronic lung disease failed to significantly slow the decline in a key measure of lung function in a late-stage study.

William blairRaghav mahobeNivedita bhattacharjeeShinjini ganguliAndy hsiehSan francisco basedIdiopathic pulmonary fibrosisLung fibrosisPulmonary fibrosisIbrosis pulmonaryClinical researchClinical trialsLinical studies

EULAR SSc Recommendations Now Include Immunosuppressants

The update to 2017 recommendations include targeted synthetic and biologic disease-modifying antirheumatic drugs for the first time.

Ariane herrickEuropean alliance of associationsEuropean congressUniversity of manchester englandBoehringer ingelheimEuropean allianceDel galdoLeeds teaching hospitalScleroderma trialsCrest syndromeBiologic therapyPulmonary hypertensionSystemic sclerosisDiffuse sclerodermaInterstitial lung diseaseHeart failure

Genetics, Lifestyle Jointly Impact IPF Risk

A large study showed a significant association between unhealthy lifestyle, genetic susceptibility, and risk for idiopathic pulmonary fibrosis.

Yudiyang maHuazhong university of scienceHuazhong universityUnited kingdom biobankIdiopathic pulmonary fibrosisRisk managementHealth risk behaviorIsky health behaviorHealth behavior changeRisk evaluation and mitigation strategies remsGenomic medicineEdicine genomicLung fibrosisPulmonary fibrosisIbrosis pulmonaryBody mass index bmi

vimarsana © 2020. All Rights Reserved.